VOR Vor Biopharma Inc. - Common Stock
$14,48
Fiyat · May 20, 2026
Temel veriler itibarıyla May 13, 2026
52 Haftlık Aralık
$3–$66
18% of range
Analist Derecelendirmesi
BUY
13 analysts
Fiyat Hedefi
$38
+162% upside
P/E (TTM)
-0.2
ROE
83.4%
Net Kâr Marjı
—
VOR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$14.47
Piyasa Değeri
$506M
P/E (TTM)
-0.2
EPS (TTM)
$-70.50
Gelir (TTM)
—
Temettü Verimi
0.00%
ROE
83.4%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$3 – $66
VOR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-70.50
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-144M
2021-12-31
→
2025-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
VOR
Akran Ortalaması
P/E (TTM)
-0.2
—
P/B (F/D)
-3.1
2.7
Price / FCF (Fiyat / Serbest Nakit Akışı)
-3.5
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
VOR
Akran Ortalaması
ROA
-229.3%
-51.1%
ROE
83.4%
-65.4%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
VOR
Akran Ortalaması
Current Ratio (Cari Oran)
18.2
7.7
Quick Ratio (Cari Oran)
18.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
VOR
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
VOR
Akran Ortalaması
Payout Ratio (Temettü Ödeme Oranı)
0.00%
—
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
0.00%
Temettü Ödeme Oranı
0.00%
5 Yıllık Temettü CAGR
—
VOR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
13 analist
- Güçlü Al 5 38,5%
- Al 6 46,2%
- Tut 2 15,4%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
8 analist · 2026-05-18
Medyan
$40.00
← Tüm hedeflerin altında
$14.47
Düşük
$18.00
Yüksek
$50.00
Medyan hedef
$40.00
+176,3%
Ortalama hedef
$37.88
+161,7%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-2.6%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-5.11 | $-0.79 | -4.3% |
| 31 Aralık 2025 | $25.84 | $-1.69 | 27.5% |
| 30 Eylül 2025 | $-3.33 | $-3.28 | -0.05% |
| 30 Haziran 2025 | $-43.80 | $-8.86 | -34.9% |
| 31 Mart 2025 | $-5.20 | $-4.62 | -0.58% |
| 31 Aralık 2024 | $-8.80 | $-5.77 | -3.0% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| DSGN | $567M | -7.7 | — | — | -32.8% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $322M | $93M | $94M | $65M | $48M | $32M | |
| SG&A Expense | $50M | $28M | $32M | $29M | $21M | $12M | |
| Operating Expenses | $372M | $121M | $126M | $93M | $69M | $43M | |
| Operating Income | $-372M | $-121M | $-126M | $-93M | $-69M | $-43M | |
| Interest Income | $6M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Other Non-op | $-324M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Net Income | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| EPS (Basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| Shares (Basic) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| Shares (Diluted) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| EBITDA | $-372M | $-121M | $-126M | $-93M | $-69M | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $396M | $82M | $31M | $58M | $120M | $49M | |
| Short-term Investments | $59M | $10M | $106M | $173M | $88M | $0 | |
| Prepaid Expense | $1M | $4M | $3M | $4M | $5M | $467.0K | |
| Other Current Assets | $2M | $380.0K | $475.0K | $2M | $2M | $100.0K | |
| Current Assets | $458M | $97M | $141M | $237M | $214M | $49M | |
| PP&E (Net) | $533.0K | $7M | $10M | $13M | $7M | $5M | |
| PP&E (Gross) | $558.0K | $18M | $18M | $17M | $9M | $5M | |
| Accum. Depreciation | $25.0K | $11M | $8M | $5M | $2M | $726.0K | |
| Other Non-current Assets | $2M | $2M | $5M | $3M | $3M | $3M | |
| Total Assets | $464M | $143M | $198M | $299M | $243M | $76M | |
| Accounts Payable | $5M | $2M | $815.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $20M | $13M | $11M | $8M | $6M | $6M | |
| Current Liabilities | $25M | $19M | $16M | $13M | $10M | $10M | |
| Capital Leases | $3M | $28M | $32M | $36M | $16M | $17M | |
| Total Liabilities | $628M | $46M | $47M | $49M | $26M | $28M | |
| Common Stock | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.15B | $-457M | $-340M | $-222M | $-130M | $-61M | |
| AOCI | $41.0K | $22.0K | $-77.0K | $-770.0K | · | · | |
| Stockholders' Equity | $-164M | $-97M | $151M | $251M | $216M | $-59M | |
| Liabilities + Equity | $464M | $143M | $198M | $299M | $243M | $76M | |
| Shares Outstanding | 38,720,196 | 6,238,799 | 3,395,072 | 65,996,138 | 37,174,741 | 505,074 |
Nakit Akışı 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $10M | $13M | $11M | $4M | $1M | |
| Restructuring | $30M | · | · | · | · | · | |
| Operating Cash Flow | $-143M | $-100M | $-100M | $-85M | $-69M | $-36M | |
| CapEx | $941.0K | $229.0K | $1M | $8M | $4M | $4M | |
| Investing Cash Flow | $-49M | $97M | $71M | $-94M | $-92M | $-4M | |
| Stock Issued | $70M | $275.0K | $5M | $4M | · | · | |
| Net Stock Activity | $70M | $275.0K | $5M | $4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $504M | $53M | $3M | $117M | $233M | $83M | |
| Net Change in Cash | $312M | $51M | $-26M | $-62M | $72M | $42M | |
| Free Cash Flow | $-144M | $-100M | $-101M | $-94M | $-73M | · |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -229.3% | -68.6% | -47.4% | -34.0% | -43.3% | · | |
| ROE | 83.4% | -137.8% | -72.4% | -45.0% | -30.7% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 | · | |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 | · |
Değerleme (TTM) 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| Market Cap | $506M | $2.77B | $3.06B | $8.78B | $8.64B | · | |
| P/E | -0.2 | -0.7 | -25.7 | -57.1 | -110.7 | · | |
| P/B | -3.1 | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Tangible Book | · | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Cash Flow | -3.5 | -27.8 | -30.5 | -103.1 | -124.9 | · | |
| P / FCF | -3.5 | -27.7 | -30.1 | -93.8 | -118.3 | · | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Earnings Yield | -539.0% | -153.3% | -3.9% | -1.8% | -0.90% | · | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 |
Gelir Tablosu 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $19M | $14M | $261M | $27M | $25M | $22M | $22M | $24M | $21M | $28M | $24M | $22M | $17M | $17M | $15M | |
| SG&A Expense | $18M | $17M | $14M | $13M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $7M | $6M | |
| Operating Expenses | $35M | $36M | $28M | $274M | $33M | $31M | $29M | $29M | $32M | $28M | $35M | $32M | $30M | $25M | $24M | $22M | |
| Operating Income | $-35M | $-36M | $-28M | $-274M | $-33M | $-31M | $-29M | $-29M | $-32M | $-28M | $-35M | $-32M | $-30M | $-25M | $-24M | $-22M | |
| Interest Income | $4M | $3M | $2M | $537.0K | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | $133.0K | |
| Other Non-op | $-184M | $1.76B | $-785M | $-1.30B | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | $133.0K | |
| Net Income | $-220M | $1.72B | $-813M | $-1.57B | $-32M | $-31M | $-28M | $-28M | $-31M | $-26M | $-33M | $-30M | $-28M | $-24M | $-24M | $-22M | |
| EPS (Basic) | $-5.11 | $63.95 | $-121.63 | $-12.56 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | $-0.58 | |
| EPS (Diluted) | $-5.11 | $63.95 | $-121.63 | $-12.56 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | $-0.58 | |
| Shares (Basic) | 43,011,544 | -246,905,522 | 6,681,794 | 125,271,447 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | 37,437,063 | |
| Shares (Diluted) | 43,011,544 | -246,905,522 | 6,681,794 | 125,271,447 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | 37,437,063 | |
| EBITDA | $-35M | · | $-28M | $-274M | $-33M | · | $-29M | $-29M | · | · | $-35M | $-32M | $-30M | · | $-24M | $-22M |
Bilanço 21
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $170M | $396M | $160M | $191M | $50M | $82M | $53M | $76M | $45M | $31M | $45M | $32M | $42M | $58M | $61M | $63M | |
| Short-term Investments | $322M | $59M | $10M | $10M | $10M | $10M | $10M | $10M | $63M | $106M | $115M | $155M | $168M | $173M | $75M | $88M | |
| Prepaid Expense | $6M | $1M | $747.0K | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $4M | $5M | $5M | |
| Other Current Assets | $3M | $2M | $1M | $449.0K | $297.0K | $380.0K | $285.0K | $272.0K | $507.0K | $475.0K | $667.0K | $539.0K | $459.0K | $2M | $2M | $2M | |
| Current Assets | $501M | $458M | $172M | $205M | $65M | $97M | $67M | $90M | $112M | $141M | $164M | $191M | $217M | $237M | $143M | $159M | |
| PP&E (Net) | $565.0K | $533.0K | $271.0K | $0 | $6M | $7M | $7M | $8M | $9M | $10M | $11M | $11M | $12M | $13M | $13M | $15M | |
| PP&E (Gross) | $618.0K | $558.0K | $272.0K | $0 | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $17M | $18M | |
| Accum. Depreciation | $53.0K | $25.0K | $1.0K | $0 | $12M | $11M | $11M | $10M | $9M | $8M | $7M | $6M | $5M | $5M | $4M | $3M | |
| Other Non-current Assets | $2M | $2M | $269.0K | $420.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Total Assets | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | $225M | |
| Accounts Payable | $1M | $5M | $885.0K | $669.0K | $4M | $2M | $1M | $2M | $2M | $815.0K | $1M | $2M | $3M | $2M | $824.0K | $1M | |
| Accrued Liabilities | $15M | $20M | $18M | $58M | $9M | $13M | $9M | $8M | $7M | $11M | $10M | $7M | $5M | $8M | $6M | $6M | |
| Current Liabilities | $16M | $25M | $19M | $59M | $17M | $19M | $14M | $14M | $13M | $16M | $15M | $13M | $13M | $13M | $11M | $12M | |
| Capital Leases | $3M | $3M | $3M | $0 | $27M | $28M | $29M | $30M | $31M | $32M | $33M | $34M | $35M | $36M | $37M | $37M | |
| Total Liabilities | $657M | $628M | $2.40B | $1.71B | $43M | $46M | $43M | $44M | $44M | $47M | $48M | $47M | $47M | $49M | $48M | $50M | |
| Common Stock | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489M | $-457M | $-426M | $-399M | $-371M | $-340M | $-314M | $-281M | $-251M | $-222M | $-198M | $-175M | |
| AOCI | $-706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K | $-70.0K | $-87.0K | $-77.0K | $-280.0K | $-436.0K | $-174.0K | $-770.0K | $-1M | $-1M | |
| Stockholders' Equity | $-150M | $-164M | $-2.23B | $-1.51B | $66M | $97M | $73M | $98M | $123M | $151M | $175M | $204M | $230M | $251M | $159M | $175M | |
| Liabilities + Equity | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | $225M | |
| Shares Outstanding | 54,185,582 | 38,720,196 | 9,026,922 | 125,645,952 | 124,851,547 | 6,238,799 | 68,663,065 | 68,357,884 | 68,215,771 | 67,891,311 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 | 37,506,236 |
Nakit Akışı 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $2M | |
| Restructuring | · | $0 | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-38M | $-23M | $-54M | $-35M | $-31M | $-24M | $-23M | $-22M | $-30M | $-24M | $-28M | $-24M | $-24M | $-18M | $-19M | $-25M | |
| CapEx | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K | $9.0K | $114.0K | $111.0K | $465.0K | $399.0K | $94.0K | $321.0K | $298.0K | $6M | |
| Investing Cash Flow | $-263M | $-49M | $-244.0K | $646.0K | $-230.0K | $-72.0K | $-34.0K | $53M | $44M | $10M | $41M | $14M | $6M | $-97M | $13M | $-3M | |
| Stock Issued | · | $50M | $20M | $0 | $0 | $-22.0K | $111.0K | $-92.0K | $278.0K | $-15.0K | $392.0K | $579.0K | $4M | $106.0K | $4M | · | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | · | · | · | · | $4M | · | · | · | |
| Financing Cash Flow | $75M | $308M | $22M | $175M | $-606.0K | $53M | $41.0K | $-31.0K | $96.0K | $25.0K | $176.0K | $218.0K | $3M | $112M | $4M | $604.0K | |
| Net Change in Cash | $-227M | $236M | $-32M | $141M | $-32M | $29M | $-23M | $31M | $14M | $-14M | $13M | $-10M | $-15M | $-3M | $-2M | $-27M | |
| Free Cash Flow | $-38M | · | · | · | $-31M | · | · | · | · | · | · | · | $-24M | · | · | · |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -71.3% | · | -556.2% | -907.1% | -23.5% | · | -16.3% | -14.2% | · | · | -15.5% | -12.6% | -11.1% | · | -10.2% | -8.7% | |
| ROE | 520.6% | · | 75.5% | 223.6% | -34.4% | · | -22.2% | -18.4% | · | · | -19.9% | -15.8% | -13.4% | · | -12.2% | -10.2% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.1 | · | 9.2 | 3.5 | 3.9 | · | 4.7 | 6.5 | · | · | 10.7 | 15.1 | 17.2 | · | 12.9 | 13.0 | |
| Quick Ratio | 30.6 | · | 9.0 | 3.4 | 3.6 | · | 4.4 | 6.2 | · | · | 10.4 | 14.7 | 16.7 | · | 12.3 | 12.3 |
Değerleme (TTM) 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-2.64B | · | $-2.45B | $-1.66B | $-119M | · | $-119M | $-122M | $-122M | · | $-115M | $-104M | $-97M | · | $-87M | $-81M | |
| Market Cap | $967M | · | $440M | $4.07B | $1.79B | · | $961M | $1.37B | · | · | $2.87B | $4.17B | $7.20B | · | $3.06B | $3.73B | |
| P/E | -0.1 | · | -0.3 | -1.5 | -1.6 | · | -1.5 | -11.1 | -26.0 | · | -21.2 | -29.6 | -47.8 | · | -34.3 | -45.4 | |
| P/B | -6.4 | · | -0.2 | -2.7 | 27.1 | · | 13.2 | 13.9 | · | · | 16.4 | 20.4 | 31.3 | · | 19.3 | 21.3 | |
| P / Tangible Book | · | · | · | · | 27.1 | · | 13.2 | 13.9 | 26.3 | · | 16.4 | 20.4 | 31.3 | · | 19.3 | 21.3 | |
| P / Cash Flow | -25.3 | · | · | · | -57.7 | · | · | · | · | · | · | · | -296.8 | · | · | · | |
| P / FCF | -25.2 | · | · | · | -57.3 | · | · | · | · | · | · | · | -295.6 | · | · | · | |
| Earnings Yield | -810.0% | · | -292.5% | -65.7% | -63.9% | · | -67.1% | -9.0% | -3.8% | · | -4.7% | -3.4% | -2.1% | · | -2.9% | -2.2% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-696M | $-117M | $-118M | $-92M | $-69M |
| Seyreltilmiş Hisse Başı Kâr | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 |
| Cari Oran | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-144M | $-100M | $-101M | $-94M | $-73M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.